643P Resistance mechanisms and efficacy of first-line (1L) alectinib in patients (pts) with ALK-rearranged non-small cell lung cancer (ALK+ NSCLC): Second interim analysis of ALCUR... von Mouri, A., Tsuda, T., Oki, M., Ichihara, E., Tanaka, H., Azuma, K., Arai, R., Kuyama, S., Akamatsu, H., Otsubo, K., Ajimizu, H., Matsumoto, M., Seto, Y., Uchibori, K., Hayashi, H., Miyauchi, E., Ishizuka, N., Kajihara, Y., Nakagawa, Y., Katayama, R.

Volltext

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small cell lung cancer von Ajimizu, H., Ozasa, H., Sato, S., Sakamori, Y., Funazo, T., Yasuda, Y., Nomizo, T., Tsuji, T., Yoshida, H., Yagi, Y., Nagai, H., Sato, A., Tsuchiya, M., Muro, S., Nagasaka, Y., Mishima, M., Kim, Y.H.

Volltext